ChemicalBook > Product Catalog >API >Nervous system drugs >Antiepileptic and anticonvulsant >Progabide

Progabide

Progabide Structure
CAS No.
62666-20-0
Chemical Name:
Progabide
Synonyms
Gabren;Gabrene;SL-76.002;progabide;Halogabide;C-abren(e);Progabide USP/EP/BP;4-[α-(p-Chlorophenyl)-5-fluoro-2-hydroxybenzylideneamino]butyramide;4-[[(4-Chlorophenyl)(5-fluoro-2hydroxyphenyl)methylene]amino]butanamide;(E)-4-((4-chlorophenyl)(5-fluoro-2-hydroxyphenyl)methyleneamino)butanamide
CBNumber:
CB1296044
Molecular Formula:
C17H16ClFN2O2
Molecular Weight:
334.77
MOL File:
62666-20-0.mol
Modify Date:
2023/9/4 15:51:00

Progabide Properties

Melting point 133-135°; mp 142.5° (Kaplan, J. Med. Chem.)
Boiling point 525.4±50.0 °C(Predicted)
Density 1.2822 (estimate)
storage temp. 2-8°C
solubility Chloroform (Slightly, Sonicated), DMSO, Methanol (Slightly, Sonicated)
form Solid
pka pKa 3.41 ± 0.04(0.4% MeOH,t=37,Iundefined)(Approximate)
color Light Yellow to Yellow
Water Solubility 37.16mg/L(37 ºC)
CAS DataBase Reference 62666-20-0

SAFETY

Risk and Safety Statements

Symbol(GHS) 
GHS07
Signal word  Warning
Hazard statements  H302-H315-H319-H335
Precautionary statements  P261-P305+P351+P338
Toxicity LD50 i.p. in mice: 900 mg/kg (Kaplan)

Progabide Chemical Properties,Uses,Production

Description

Progabide is a broad-spectrum anticonvulsant agent indicated for the treatment of a wide variety of seizure disorders. Synthesized as a GABA-prodrug, anticonvulsant activity appears due to the parent drug and its acid metabolite, as well as to GABAmide and GABA liberated therefrom.

Chemical Properties

Bright Yellow Solid

Uses

Progabide is a gamma-aminobutyric acid (GABA) antagonist with antiepileptic activity.

World Health Organization (WHO)

Progabide, an anticonvulsant, was introduced in France in 1985 for the treatment of epilepsy. Its use has occasionally been associated with clinically evident signs of icteric hepatitis developing within the first six months of treatment. These signs are generally reversible on withdrawal of the drug but continuation of treatment has been associated with three reported fatalities (two of which are doubtfully related to the drug). The manufacturer revised the data sheet in March 1986 advising that use of progabide should be reserved for patients unresponsive to other anticonvulsants.

Progabide Preparation Products And Raw materials

Raw materials

chevron_left

1of2

chevron_right

Preparation Products

Global( 52)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
CLEARSYNTH LABS LTD. +91-22-45045900 Hyderabad, India 6351 58 Inquiry
ATK CHEMICAL COMPANY LIMITED +undefined-21-51877795 China 32760 60 Inquiry
CONIER CHEM AND PHARMA LIMITED +8618523575427 China 49391 58 Inquiry
TargetMol Chemicals Inc. +1-781-999-5354 +1-00000000000 United States 19892 58 Inquiry
Dideu Industries Group Limited +86-29-89586680 +86-15129568250 China 26063 58 Inquiry
Amadis Chemical Company Limited 571-89925085 China 131980 58 Inquiry
Shanghai Hao Zhun Biological Technology Co., Ltd. 15800340161 CHINA 6846 58 Inquiry
Guangzhou Weijia Technology Co., Ltd. 020-84224925 18300190102 CHINA 6748 58 Inquiry
Shanghai Hao Biological Technology Co., Ltd. 021-80370006 13585899102 CHINA 6805 58 Inquiry
Shanghai Yubo Biotechnology Co., Ltd. 021-51875103 15026509758 CHINA 6322 58 Inquiry

Progabide Spectrum

progabide BUTANAMIDE, 4-[[(4-CHLOROPHENYL)(5-FLUORO-2-HYDROXYPHENYL)METHYLENE]AMINO]- Halogabide (E)-4-((4-chlorophenyl)(5-fluoro-2-hydroxyphenyl)methyleneamino)butanamide 4-[[(Z)-(4-Chlorophenyl)-(3-fluoro-6-oxo-1-cyclohexa-2,4-dienylidene)methyl]amino]butanamide 4-[[(4-Chlorophenyl)(5-fluoro-2hydroxyphenyl)methylene]amino]butanamide C-abren(e) SL-76.002 4-[α-(p-Chlorophenyl)-5-fluoro-2-hydroxybenzylideneamino]butyramide Gabren Gabrene Progabide USP/EP/BP 62666-20-0 C17H16ClFN2O2 Amines Aromatics Intermediates & Fine Chemicals Pharmaceuticals